← Leaderboards
Christopher C. Oakes
Ohio State University
$2,619,311
Attributed
$6,608,481
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2021–25$2.5M$1.9M$1.3M$625K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,608,481 · 2
By mechanism
R01$6,608,481 · 2
Top collaborators
- Bethany Mundy-Bosse5 shared
- Esteban Braggio4 shared
- Susan L Slager4 shared
Most similar at Ohio State University
Same institution · by research overlap
- Timiya S Nolan$1,866,508
- Bethany Mundy-Bosse$1,809,973
- Jennifer A. Woyach$6,733,332
- Anna E Vilgelm$2,524,271
- Kerry Anne Rogers$1,321,382
Others in their field
Other Emerging Leaders on “Dna Methylation”
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Chongyuan Luo · University Of California Los Angeles$9,805,856
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Michael-Christopher Keogh · Epicypher, Inc.$8,161,366
- Carl Rhodes · University Of Washington$8,047,567
- Himisha Beltran · Dana-Farber Cancer Inst$7,515,798
Research focus
Dna MethylationLeukemiaEpigenetic ProcessMalignant NeoplasmsPublic HealthEvaluationUnited StatesImmunophenotypingDisease ProgressionAutomobile DrivingCellsAcute Myeloid Leukemia CellCoculture TechniquesCessation Of LifeDisorder ControlAryl Hydrocarbon Receptor LigandCd34 GeneAcute Myelocytic LeukemiaDefectAryl Hydrocarbon ReceptorCell Differentiation ProcessCell LineageCell PhysiologyAberrant Dna Methylation
Grant awards (9)
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$1,651,283
R01 · FY2025 · CA
Dysregulation of Innate Lymphoid Immunity in Acute Myeloid Leukemia$506,825
R01 · FY2025 · CA
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$783,300
R01 · FY2024 · CA
Dysregulation of Innate Lymphoid Immunity in Acute Myeloid Leukemia$481,484
R01 · FY2024 · CA
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$804,919
R01 · FY2023 · CA
Dysregulation of Innate Lymphoid Immunity in Acute Myeloid Leukemia$496,689
R01 · FY2023 · CA
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$870,073
R01 · FY2022 · CA
Dysregulation of Innate Lymphoid Immunity in Acute Myeloid Leukemia$499,474
R01 · FY2022 · CA
Dysregulation of Innate Lymphoid Immunity in Acute Myeloid Leukemia$514,434
R01 · FY2021 · CA